Education
About Us
Working with TipRanks
Follow Us
NanoCarrier Co., Ltd. (JP:4571)
:4571
RESEARCH TOOLSreports
4571 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥113.00 - ¥230.00
Previous CloseN/A
Volume236.30K
Average Volume (3M)978.39K
Market Cap
¥9.11B
Enterprise ValueN/A
Total Cash (Recent Filing)¥3.52B
Total Debt (Recent Filing)¥540.00M
Price to Earnings (P/E)―
Beta0.72
Next Earnings
Aug 08, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.40
Shares Outstanding70,625,460
10 Day Avg. Volume651,040
30 Day Avg. Volume978,393
Financial Highlights & Ratios
PEG Ratio-0.79
Price to Book (P/B)3.77
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
98.96% Public Companies and
Individual Investors
4571 FAQ
What was NanoCarrier Co., Ltd.’s price range in the past 12 months?
NanoCarrier Co., Ltd. lowest stock price was ¥113.00 and its highest was ¥230.00 in the past 12 months.
What is NanoCarrier Co., Ltd.’s market cap?
NanoCarrier Co., Ltd.’s market cap is ¥9.11B.
When is NanoCarrier Co., Ltd.’s upcoming earnings report date?
NanoCarrier Co., Ltd.’s upcoming earnings report date is Aug 08, 2025 which is in 78 days.
How were NanoCarrier Co., Ltd.’s earnings last quarter?
NanoCarrier Co., Ltd. released its earnings results on May 14, 2025. The company reported -¥3.4 earnings per share for the quarter, missing the consensus estimate of N/A by -¥3.4.
Is NanoCarrier Co., Ltd. overvalued?
According to Wall Street analysts NanoCarrier Co., Ltd.’s price is currently Overvalued.
Does NanoCarrier Co., Ltd. pay dividends?
NanoCarrier Co., Ltd. does not currently pay dividends.
What is NanoCarrier Co., Ltd.’s EPS estimate?
NanoCarrier Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NanoCarrier Co., Ltd. have?
NanoCarrier Co., Ltd. has 70,625,460 shares outstanding.
What happened to NanoCarrier Co., Ltd.’s price movement after its last earnings report?
NanoCarrier Co., Ltd. reported an EPS of -¥3.4 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.481%.
Which hedge fund is a major shareholder of NanoCarrier Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4571
Company Description
NanoCarrier Co., Ltd.
NanoCarrier Co., Ltd. researches, develops, produces, and sells pharmaceuticals using micelle nanoparticle technology primarily for the treatment of cancer in Japan. The company's product pipeline includes VB-111 non-proliferative adenovirus vector, which is in phase III clinical trials for the treatment of ovarian cancer, as well as in phase II clinical trials for treatment of rGBM and colorectal cancer; ENT103 Otolaryngology product that is in phase III clinical trials for the treatment of otitis media; NC-6004 Cisplatin micelle, which is in phase II clinical trials for the treatment of head and neck cancer; NC-6300 Epirubicin micelle that is in phase I clinical trials for the treatment of hemangiosarcoma; and NC-6100 PRDM14 (siRNA), which is in phase I clinical trials for the treatment of breast cancer. Its product pipeline also comprises TUG1 (ASO) for glioblastoma and RUNX1 (mRNA) for osteoarthritis of the knee that are in preclinical stage. The company was founded in 1996 and is headquartered in Tokyo, Japan.
Technical Analysis
Daiichi Sankyo Company
―
Shionogi & Co
―
Daito Pharmaceutical Co., Ltd.
―
RaQualia Pharma Inc.
―
Symbio Pharmaceuticals Limited
―